Introduction of exogenous IL-13 into murine airways resulted in lymphocytic and eosinophilic inflammation, airway remodeling, and airway hyperresponsiveness (AHR) [3, 4]. The gene discussed is IL13; the disease is airway hyperresponsiveness.